Creatine and guanidinoacetate transport at blood‐brain and blood‐cerebrospinal fluid barriers
- 18 January 2012
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 35 (4), 655-664
- https://doi.org/10.1007/s10545-011-9433-2
Abstract
While it was thought that most of cerebral creatine is of peripheral origin, AGAT and GAMT are well expressed in CNS where brain cells synthesize creatine. While the creatine transporter SLC6A8 is expressed by microcapillary endothelial cells (MCEC) at blood-brain barrier (BBB), it is absent from their surrounding astrocytes. This raised the concept that BBB has a limited permeability for peripheral creatine, and that the brain supplies a part of its creatine by endogenous synthesis. This review brings together the latest data on creatine and guanidinoacetate transport through BBB and blood-CSF barrier (BCSFB) with the clinical evidence of AGAT-, GAMT- and SLC6A8-deficient patients, in order to delineate a clearer view on the roles of BBB and BCSFB in the transport of creatine and guanidinoacetate between periphery and CNS, and on brain synthesis and transport of creatine. It shows that in physiological conditions, creatine is taken up by CNS from periphery through SLC6A8 at BBB, but in limited amounts, and that CNS also needs its own creatine synthesis. No uptake of guanidinoacetate from periphery occurs at BBB except under GAMT deficiency, but a net exit of guanidinoacetate seems to occur from CSF to blood at BCSFB, predominantly through the taurine transporter TauT.Keywords
This publication has 96 references indexed in Scilit:
- A maternal diet supplemented with creatine from mid-pregnancy protects the newborn spiny mouse brain from birth hypoxiaNeuroscience, 2011
- Long‐term follow‐up and treatment in nine boys with X‐linked creatine transporter defectJournal of Inherited Metabolic Disease, 2011
- Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disordersFluids and Barriers of the CNS, 2011
- Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 2011
- Evolutionary evidence of the effect of rare variants on disease etiologyClinical Genetics, 2010
- Response to creatine analogs in fibroblasts and patients with creatine transporter deficiencyMolecular Genetics and Metabolism, 2010
- Non-enzymatic cyclization of creatine ethyl ester to creatinineBiochemical and Biophysical Research Communications, 2009
- Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouseBMC Developmental Biology, 2009
- Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: Early treatment can prevent phenotypic expression of the diseaseThe Journal of Pediatrics, 2006
- The Putative Rat Choline Transporter CHOT1 Transports Creatine and Is Highly Expressed in Neural and Muscle-Rich TissuesBiochemical and Biophysical Research Communications, 1994